Navigation Links
Vioxx Settlement Announced
Date:11/9/2007

TAMPA, Fla., Nov. 9 /PRNewswire/ -- After several years of litigation, Merck has agreed to pay $4.85 billion in a settlement over Vioxx. The medication was pulled off the market in 2004 after a clinical trial proved it increased the risks of heart attacks and strokes. It is one of the largest pharmaceutical settlements in history.

James Hoyer Newcomer and Smiljanich is pleased this long process is coming to a resolution. The firm has more than a dozen clients who've suffered the ill-effects of taking Vioxx. "This settlement was a long time coming, but one that will finally give our clients some relief from the harm they suffered," said Attorney John Newcomer.

Nearly 30-thousand lawsuits have been filed nationwide against Merck because of Vioxx. Plaintiffs will receive different settlement payments depending on the severity of their injuries and the length of time they took Vioxx. Plaintiff Alvin Jupiter, of Tampa, suffered a heart attack in 2001 after taking Vioxx. He said, "I'm glad to see something coming to fruition on this. So many people were hurt."

James Hoyer Newcomer & Smiljanich will review details of the settlement over the coming weeks and work to ensure our clients are compensated fairly.


'/>"/>
SOURCE James Hoyer Newcomer & Smiljanich
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. New study may explain Vioxx side-effects
2. Study Points to Cause of Vioxx Heart Risk
3. Vioxx Ban Tied to Rise in Serious GI Trouble
4. The Lanier Law Firm Announces $4.85 Billion National Vioxx Settlement With Merck & Co. Inc.
5. Vioxx Settlement Puts Painkillers Back in the Spotlight
6. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
7. MaxLife Fund Corp. purchases a portfolio of Life Settlement Policies with a face value of $4,000,000
8. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
9. $52.5 Million Settlement Against Sepracor Inc. Approved
10. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
11. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... San Ramon, CA (PRWEB) , ... March 22, ... ... and tissue recovery agency for northern California and Nevada and LABS, Inc., announced ... in rapid turnaround (STAT) infectious disease screening and serology testing used to ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Rett Syndrome Research ... neurological disorder that afflicts 350,000 individuals worldwide. Rett Syndrome is caused by ... exclusively strikes females. Following a normal infancy, Rett Syndrome takes effect in ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Burke Medical Research Institute ... advances in basic neuroscience at the BMRI labs into new and improved treatments ... movement, vision, and cognition impaired by stroke, traumatic brain injury, cerebral palsy, and ...
(Date:3/22/2017)... ... March 22, 2017 , ... SNL Insurance and ... families and business owners in the greater Hampton Roads area, is embarking on ... Relay For Life event. , Each year, hundreds of people living in the ...
(Date:3/22/2017)... ... ... Schneider Insurance and Financial, a southern Montana firm providing asset protection and ... launching a charity event aimed at raising local support for Zoo Montana. , Zoo ... is home to a broad variety of animals from all over the world. Many ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)...  ImaginAb Inc. today announced the appointment of Martyn Coombs ... , chairman of ImaginAb, said "At ImaginAb we have exciting science ... relevant to our business, particularly in commercializing and making step changes ... we can realize our potential." ... Mr. Coombs is a recognized industry leader in nuclear ...
(Date:3/22/2017)... 2017 Research and Markets has announced ... Market & Clinical Pipeline Insight 2022" drug pipelines to ... ... Pipeline Insight 2022 report gives comprehensive insight on clinical and ... check point inhibitors as main streamline drugs in the immunotherapy ...
(Date:3/22/2017)... LINCOLN, Mass. , March 22, 2017 /PRNewswire/ ... applying mechanistic modeling to drug research and development, ... QSP Day 2017.  QSP Day 2017 is a ... with the quantitative systems pharmacology (QSP) community. The ... mathematical modeling is de-risking and accelerating drug research ...
Breaking Medicine Technology: